Series A
CNY 200M
Tiantu CapitalXtalPiLegend CapitalChina Life Equity Investment · LeadYayi Capital
Open roles0
Total raised¥200M
Team size11-50
Founded · Stage2022 · Series A
We pull jobs from sources most job seekers never check
About the company
What they build and who they serve.
Xellar Biosystems (耀速科技, also trading as Xellar Technology) is a Chinese biotech building an AI + organ-on-a-chip closed-loop platform dubbed 3D-Wet-AI for preclinical drug testing. Founded in 2021, it is the only Chinese company selected for the US FDA's program to validate new alternative methods (NAMs) replacing animal testing, and maintains strategic partnerships with XtalPi on quantum-AI drug design and with Korea's WOOJUNG BIO on hybrid human-OoC plus animal preclinical platforms.
Why it matters
Signals from funding, traction, and product direction.
- Only Chinese company selected for the US FDA program to validate new alternative methods (NAMs) — positioning Xellar at the center of the global regulatory shift away from animal testing in drug development.
- Platform: AI + organ-on-a-chip (OoC) closed loop dubbed '3D-Wet-AI' — combines wet-lab experiments with image-based AI to provide holistic interconnected preclinical drug-testing models.
- Strategic partnerships: WOOJUNG BIO (Korea) multi-year hybrid human-OoC + animal preclinical platform partnership (Jan 2026); prior XtalPi partnership (April 2025) integrating quantum-physics-based AI drug design with organ-chip readouts.
- Amount is CNY 200M+ (~$29M) per edgen.tech — original currency is RMB, not USD. Prior rounds: Seed (Aug 2022), Seed II ($14M, July 2024), Seed III (XtalPi, April 2025).
- Lead China Life Equity Investment represents Chinese sovereign-aligned insurance capital entering the biotech deep-tech space — signals strategic national interest in the OoC / NAMs category.
Funding history
Rounds and investors over time, newest first.
In the news
Press, announcements, and coverage about this company.
Investors
Tiantu CapitalXtalPiLegend CapitalChina Life Equity InvestmentYayi Capital
Focus areas
AI/MLDeep TechBiotechnologyClinical TrialsHealthtech
No open roles on the board yet
We do not have indexed listings for Xellar Biosystems right now. Roles may still be open on the company site—we will add them here when they appear in our feed.
Don’t get beat to tomorrow’s openings
New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job posts